Back
Nuveen Credit Strategies Income Fund Vs. Hims & Hers Health Industry Stock Comparison
Buy
61
JQC
Nuveen Credit Strategies Income Fund
Last Price:
$5.52
Seasonality Move:
-1.7%
Sell
43
HIMS
Hims & Hers Health
Last Price:
$50.36
Seasonality Move:
-12.28%
Buy
61
Nuveen Credit Strategies Income Fund (JQC)
is a Buy
Is Nuveen Credit Strategies Income Fund a Buy, Sell or Hold?
-
The current Nuveen Credit Strategies Income Fund [JQC] share price is $5.50. The Score for JQC is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
JQC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Hims & Hers Health (HIMS)
is a Sell
Is Hims & Hers Health a Buy, Sell or Hold?
-
The current Hims & Hers Health [HIMS] share price is $50.38. The Score for HIMS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
HIMS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JQC Stock Price Chart
What is Nuveen Credit Strategies Income Fund's stock price today?
-
The Nuveen Credit Strategies Income Fund share price today is $5.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JQC is experiencing buying pressure, which is a positive indicator for future bullish movement.
HIMS Stock Price Chart
What is Hims & Hers Health's stock price today?
-
The Hims & Hers Health share price today is $50.38Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HIMS is experiencing slight buying pressure.
JQC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.52 | Buy |
Relative Strength Index (14 RSI): | 64.87 | Buy |
Chaikin Money Flow: | 2433725 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.32 - 5.48) | Buy |
Bollinger Bands (100): | (5.16 - 5.48) | Buy |
HIMS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 14.05 | Buy |
Relative Strength Index (14 RSI): | 49.62 | Sell |
Chaikin Money Flow: | 10224056 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.3 - 56.6) | Sell |
Bollinger Bands (100): | (31.93 - 55.19) | Buy |
JQC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.47 | Buy |
20-day SMA: | 5.42 | Buy |
50-day SMA: | 5.34 | Buy |
200-day SMA: | 5.52 | Sell |
8-day EMA: | 4.9 | Buy |
20-day EMA: | 3.25 | Buy |
50-day EMA: | 1.65 | Buy |
200-day EMA: | 0.47 | Buy |
HIMS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.51 | Sell |
20-day SMA: | 49.05 | Buy |
50-day SMA: | 53.65 | Sell |
200-day SMA: | 36.13 | Buy |
8-day EMA: | 45.23 | Buy |
20-day EMA: | 29.93 | Buy |
50-day EMA: | 15.23 | Buy |
200-day EMA: | 4.33 | Buy |
Nuveen Credit Strategies Income Fund Earnings Growth & JQC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Hims & Hers Health Earnings Growth & HIMS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.10 per share, an increase this year of $0.19 per share, and an increase next year of $0.34 per share.
Nuveen Credit Strategies Income Fund Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Hims & Hers Health Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |